Research Article
The Effects of Diabetic Duration on Lacrimal Functional Unit in Patients with Type II Diabetes
Table 2
Demographics of diabetic subgroups and control group.
| | Demographics | Controls | Diabetic patients | | <10 y | 10∼20 y | ≥21 y | Total |
| | Subject (n) | 51 | 28 | 39 | 24 | 91 | | M : F ratio | 18 : 33 | 11 : 17 | 18 : 21 | 14 : 10 | 40 : 51 | | Age (y) | 64.35 ± 5.66 | 64.93 ± 6.03 | 65.54 ± 6.41 | 65.83 ± 6.57 | 65.43 ± 6.31 | | HbA1c (%) | — | 6.94 ± 0.43 | 7.00 ± 0.51 | 6.87 ± 0.53 | 6.95 ± 0.49 | | Duration (y) | 0 | 4.18 ± 2.02 | 13.67 ± 2.46 | 24.22 ± 4.81 | 13.58 ± 8.27 | | DR (no. of eyes) | 0 | 56 | 78 | 48 | 182 | | NDR (n (%)) | 0 | 42 (75) | 11 (14.1) | 0 | 53 (29.1) | | NPDR (n (%)) | 0 | 14 (25) | 67 (85.9) | 48 (100) | 129 (70.9) | | PDR (%) | 0 | 0 | 0 | 0 | 0 |
|
|
Note: duration, duration of diabetes; DR, diabetic retinopathy; NDR, no diabetic retinopathy; NPDR, nonproliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy.
|
